Nolla Health 成为美国首家获监管批准由 AI 开具初始处方的机构。Rohan Paul 介绍，Nolla 在犹他州为符合条件的成人轻中度痤疮病例提供从问诊、皮肤扫描、评估到处方和随访的完整流程，处方限于固定清单内的外用药膏和凝胶，并转给持证药剂师，医师逐一审核早期病例后再逐步放宽监督。
原文说明了监管批准覆盖的具体边界和保障结构，读者可以据此理解这类AI处方与普通健康聊天机器人的差别。
Healthcare is probably AI's highest-stakes real-world test.
Most consumer health AI ends in the same spot: a suggestion and a prompt to book an appointment.
@nollahealth now takes eligible acne cases in Utah all the way through.
The AI handles intake, a skin scan, assessment, the prescription and follow-up, and a clinician steps in when needed.
Plenty of models can label acne in a photo. None in the U.S. had been cleared to write a first prescription.
What Utah signed off on is the structure around Nolla's model: adults only, mild to moderate acne, a set list of topical creams and gels, prescriptions routed to a licensed pharmacist, and physicians reviewing every early case before oversight steps down.
Today, Nolla Health became the first organization in the U.S. (and possibly the world) to receive regulatory approval for an AI to issue initial prescriptions. This makes Nolla the first ever actual end-to-end AI doctor.在 X 查看被引用的帖子
来源：Rohan Paul · x.com